Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
Public ClinicalTrials.gov record NCT01265849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III Study of LI [Multikine®] Plus SOC (Surgery + Radiotherapy or Surgery + Concurrent Radiochemotherapy) in Subjects With Advanced Primary Squamous Cell Carcinoma of the Oral Cavity/Soft Palate vs. SOC Only
Study identification
- NCT ID
- NCT01265849
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- CEL-SCI Corporation
- Industry
- Enrollment
- 928 participants
Conditions and interventions
Interventions
- LI Biological
- Cyclophosphamide Drug
- Indomethacin Drug
- Zinc Dietary Supplement
- Surgery Procedure
- Cisplatin Drug
- Radiotherapy Radiation
Biological · Drug · Dietary Supplement + 2 more
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2010
- Primary completion
- May 14, 2020
- Completion
- Dec 3, 2020
- Last update posted
- Aug 18, 2022
2010 – 2020
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Simmons Cancer Institute at Southern Illinois University | Springfield | Illinois | 62794 | — |
| Henry Ford Health System Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | — |
| Medical College Of South Carolina MSC550 | Charleston | South Carolina | 29435 | — |
| VA Puget Sound Healthcare System & University of WA | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 97 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01265849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01265849 live on ClinicalTrials.gov.